Group A Streptococcus invasive infections: A review

Canadian Journal of Surgery

Volumn 40, Issue 1, 1997, Pages 18-25

  Weiss, Karl A ^a   Laverdière, Michel ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; ERYTHROMYCIN; IMMUNOGLOBULIN; PENICILLIN G;

BACTERIAL INFECTION; CLINICAL FEATURE; DISEASE COURSE; HUMAN; PATHOPHYSIOLOGY; REVIEW; STREPTOCOCCUS GROUP A; SYMPTOMATOLOGY;

ADULT; ANIMALS; DISEASE MODELS, ANIMAL; FASCIITIS, NECROTIZING; HUMANS; MIDDLE AGED; MYOSITIS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0031055727     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jameson F, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16(6):792-802.
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study [published erratum appears in JAMA 1993; 269(13):1638] [see comment]. JAMA 1993;269: 384-9. Comment in: JAMA 1993; 269(3):390-1.
3. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study [published erratum appears in JAMA 1993; 269(13):1638] [see comment]. JAMA 1993;269: 384-9. Comment in: JAMA 1993; 269(3):390-1.
4. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shocklike syndrome and scarlet fever toxin A [see comment]. N Engl J Med 1989; 321(1):1-6. Comment in: N Engl J Med 1989; 321(22):1545-7.
5. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shocklike syndrome and scarlet fever toxin A [see comment]. N Engl J Med 1989; 321(1):1-6. Comment in: N Engl J Med 1989; 321(22):1545-7.
6. Martin PR, Holby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22:421-9.
7. Defining the group A streptococcal toxic shock syndrome. The Working Group on Severe Streptococcal Infections [comment]. JAMA 1993;269: 390-1. Comment on: JAMA 1993; 266(3):384-9.
8. Defining the group A streptococcal toxic shock syndrome. The Working Group on Severe Streptococcal Infections [comment]. JAMA 1993;269: 390-1. Comment on: JAMA 1993; 266(3):384-9.
9. Yoder EL, Mendez J, Khatib R. Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature. Rev Infect Dis 1987;9:382-5.
10. Barker FG, Leppard BJ, Seal DV. Streptococcal necrotising fasciitis: comparison between histological and clinical features. J Clin Pathol 1987; 40:335-41.
11. Farley JD, Woo V, Shaw C, Smith JA. Invasive streptococcal disease in British Columbia. Can Dis Wkly Rep 1990;16:257-9.
12. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates [see comment]. JAMA 1991;266(4):533-7. Comment in: JAMA 1992;267(1):53.
13. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates [see comment]. JAMA 1991;266(4):533-7. Comment in: JAMA 1992;267(1):53.
14. Demers B, Low DE, Simor AE, Vellend H, Jamieson F, Walmsley S, et al. Severe group A streptococcal disease - southern Ontario. Ontario Streptococcal Study Group. Can Dis Wkly Rep 1991;17(35):192-4.
15. Stevens DL. Invasive group A Streptococcus infections. Clin Infect Dis 1992;14:2-13.
16. Chelsom J, Halstensen A, Haga A, Hoiby EA. Necrotising fasciitis due to GAS in western Norway: incidence and clinical features. Lancet 1994; 344:1111-5.
17. Brogan TV, Nizet V, Waldhausen JH, Rubens CE, Clarke WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995;14(7):588-94.
18. Forni AL, Kaplan EL, Schlievert PM, Roberts RB. Clinical and microbiological characteristics of severe group A Streptococcus infections and STSS. Clin Infect Dis 1995;21:333-40.
19. Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992;14: 298-307.
20. Bisno AL. The rise and fall of rheumatic fever. JAMA 1985;254: 538-41.
21. Stromberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991;164:595-8.
22. Griffith F. The serological classification of Streptococcus pyogenes. J Hyg (Lond)1984;34:542-84.
23. Stollerman GH. Changing group A streptococci. The reappearance of streptococcal "toxic shock" [editorial] [published erratum appears in Arch Intern Med 1988;148(12):2600]. Arch Intern Med 1988;148(6):1268-70.
24. Low DE, Kaul R, McGeer A. Severe invasive group A streptococcal infections: pathogenesis and possible new approaches to treatment. Can Infect Dis Soc Newsl April 1995.
25. Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992;166(1):31-7.
26. Bisno AL. Streptococcus pyogenes. In Mandell GL, editor. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1994:1786-99.
27. Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 1995;33: 2382-7.
28. Pfanner W. Zur Kenntnis und Behandlung des nekrotisierenden Erysepels. Dtsche Z Chir 1918;144:108.
29. Meleney FL. Hemolytic Streptococcus gangrene. Arch Surg 1924;9:317-64.
30. Wilson B. Necrotizing fasciitis. Am Surg 1952;18:416-31.
31. Aitken DR, Mackett MC, Smith LL. The changing pattern of hemolytic streptococcal gangrene. Arch Surg 1982;117:561-7.
32. Stamenkovic I, Lew D. Early recognition of potentially fatal necrotizing fasciitis. N Engl J Med 1984;310: 1689-93.
33. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR, et al. Streptococcal myositis. Arch Intern Med 1985;145(6): 1020-23.
34. Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis 1992;15:668-77.
35. Halsted WS: Surgical papers. Baltimore: Johns Hopkins Press, 1924:103.
36. Abbott L. Invasive streptococcal disease - Prince Edward Island. Can Dis Wkly Rep 1991;17:191.
37. Weiss K, Roger M, Maziade PJ, Frenettte C, LeCorre I, Delorme J, et al. A household cluster of fulminant group A Streptococcus pneumoniae associated with toxic shock syndrome - Quebec. Can Commun Dis Rep 1996;22(6):41-3.
38. Bartter T, Dascal A, Carroll K , Curley FJ. "Toxic strep syndrome." A manifestation of group A streptococcal infection [see comment]. Arch Intern Med 1988;148(6):1421-4. Comment in: Arch Intern Med 1992; 152(4):882,884.
39. Bartter T, Dascal A, Carroll K , Curley FJ. "Toxic strep syndrome." A manifestation of group A streptococcal infection [see comment]. Arch Intern Med 1988;148(6):1421-4. Comment in: Arch Intern Med 1992; 152(4):882,884.
40. Eagle H. Experimental approach to the problem of treatment failure with penicillin in group A Streptococcus infection in mice. Am J Med 1952; 13:389-99.
41. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8.
42. Stevens DL. STSS: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-77.
43. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-5.
44. Kaul R, McGeer A, CIDS Study Project, Norrby-Teglund A, Kotb M, Low DE. Intravenous immunoglobulin therapy in streptococcal toxic shock syndrome: results of a matched case-control study [abstract]. Presented at the 35th International Conference on Antimicrobial Agents and Chemotherapy meeting, San Francisco, Calif. 1995:LM68
45. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Kotb M. Intravenous immunoglobulin and superantigen-neutralizing activity in streptococcal toxic shock syndrome patients. Presented at the 35th International Conference on Antimicrobial Agents and Chemotherapy meeting, San Francisco, Calif. 1995:LM67
46. Schwartz B, Elliott JA, Butler JC, Butler PA, Jameson BL,Welch GE, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992;15(2):277-84.
47. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group [see comment]. N Engl J Med 1996;335(8):547-54. Comment in:N Engl J Med 1996;335(8):590-1.
48. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group [see comment]. N Engl J Med 1996;335(8):547-54. Comment in:N Engl J Med 1996;335(8):590-1.
49. Weiss K, Laverdière M, Delorme J, Poirier L, Belliveau C, Robert A. Group A Streptococcus carriage in contacts of patients with invasive infections: an epidemiological survey [abstract]. Presented at the 36th International Conference on Antimicrobial Agents and Chemotherapy meeting, New Orleans, La. 1996: K73.
50. Davies HD, Low DE, Schwartz B, Scriver S, Fletcher A, O'Rourke K, et al. Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group. Clin Infect Dis 1995;21(5): 1294-9.